[go: up one dir, main page]

Academia.eduAcademia.edu

JCMA 2012-Brain sono-Shu

Abstract

Background: Ultrasonography is a non-invasive diagnostic technique, and it has been used to detect intracranial lesions in neonates for a long time. Correspondingly, screening tests using cranial ultrasonography have been applied for early detection of intracranial lesions in full-term neonates during the past decade. Methods: We retrospectively reviewed the findings of cranial ultrasonographic screening tests in healthy full-term neonates between September 2004 and August 2009. The ultrasonographic findings were divided into the following categories: (a) nonsignificant (NS) group, including normal and normal variations, (b) minor anomaly group, including tiny cystic lesions, mild hemorrhage, or mild ventricular anomaly, and (c) major anomaly group, including significant anomaly of any intracranial pathology. The participants with major anomalies were further reviewed, and the following medical records of all enrolled patients were reviewed until they were 24 months of age. Results: There were a total of 3186 neonates who received cranial ultrasonographic screening examination during the 5-year period, and most of them (2982 cases, 93.6%) were assigned to the NS group. The most common normal variation was the presence of cavum septum pellucidum (1979 cases, 62.1%). Minor anomalies were found in 202 (6.3%) neonates, including 119 (3.7%) neonates with tiny cysts, and 59 (1.9%) neonates with mild intraventricular hemorrhage. Major anomalies were found in two (0.06%) neonates, including obstructive hydrocephalus and agenesis of the corpus callosum. Two other infants (0.06%) initially presented with minor anomaly or normal variation, but they were diagnosed as Moyamoya disease and neonatal seizure some months later. Conclusion: The incidence of minor and major anomalies detected by cranial ultrasonographic screening examinations in healthy full-term neonates is 6.3% and 0.06%, respectively. Thus, cranial ultrasonographic screening testing may play a role in the early diagnosis of intracranial anomalies of otherwise healthy neonates. However, this examination cannot exclude or detect all cranial abnormalities, including many potential neurologic diseases of neonates, so continuing clinical diligence is still important for all infants.

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and sharing with colleagues. Other uses, including reproduction and distribution, or selling or licensing copies, or posting to personal, institutional or third party websites are prohibited. In most cases authors are permitted to post their version of the article (e.g. in Word or Tex form) to their personal website or institutional repository. Authors requiring further information regarding Elsevier’s archiving and manuscript policies are encouraged to visit: http://www.elsevier.com/copyright Author's personal copy Available online at www.sciencedirect.com Journal of the Chinese Medical Association 75 (2012) 389e395 www.jcma-online.com Original Article Cranial ultrasonographic findings in healthy full-term neonates: A retrospective review Chien-Lun Hsu a, Kang-Lung Lee a,c, Mei-Jy Jeng a,b,c,*, Kai-Ping Chang a, Chia-Feng Yang a,b,c, Pei-Chen Tsao a,b,c, Yu-Sheng Lee a,c, Shu-Jen Chen a,c, Wen-Jue Soong a,b,c, Ren-Bin Tang a,c a Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, ROC b Institute of Emergency and Critical Care Medicine, Taipei, Taiwan, ROC c Department of Pediatrics, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC Received March 12, 2012; accepted April 15, 2012 Abstract Background: Ultrasonography is a non-invasive diagnostic technique, and it has been used to detect intracranial lesions in neonates for a long time. Correspondingly, screening tests using cranial ultrasonography have been applied for early detection of intracranial lesions in full-term neonates during the past decade. Methods: We retrospectively reviewed the findings of cranial ultrasonographic screening tests in healthy full-term neonates between September 2004 and August 2009. The ultrasonographic findings were divided into the following categories: (a) nonsignificant (NS) group, including normal and normal variations, (b) minor anomaly group, including tiny cystic lesions, mild hemorrhage, or mild ventricular anomaly, and (c) major anomaly group, including significant anomaly of any intracranial pathology. The participants with major anomalies were further reviewed, and the following medical records of all enrolled patients were reviewed until they were 24 months of age. Results: There were a total of 3186 neonates who received cranial ultrasonographic screening examination during the 5-year period, and most of them (2982 cases, 93.6%) were assigned to the NS group. The most common normal variation was the presence of cavum septum pellucidum (1979 cases, 62.1%). Minor anomalies were found in 202 (6.3%) neonates, including 119 (3.7%) neonates with tiny cysts, and 59 (1.9%) neonates with mild intraventricular hemorrhage. Major anomalies were found in two (0.06%) neonates, including obstructive hydrocephalus and agenesis of the corpus callosum. Two other infants (0.06%) initially presented with minor anomaly or normal variation, but they were diagnosed as Moyamoya disease and neonatal seizure some months later. Conclusion: The incidence of minor and major anomalies detected by cranial ultrasonographic screening examinations in healthy full-term neonates is 6.3% and 0.06%, respectively. Thus, cranial ultrasonographic screening testing may play a role in the early diagnosis of intracranial anomalies of otherwise healthy neonates. However, this examination cannot exclude or detect all cranial abnormalities, including many potential neurologic diseases of neonates, so continuing clinical diligence is still important for all infants. Copyright Ó 2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved. Keywords: brain; neonate; newborn screening; ultrasonography 1. Introduction Ultrasonography is a non-invasive technique of deep tissue structure image study that has proven useful in detecting * Corresponding author. Dr. Mei-Jy Jeng, Department of Pediatrics, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, ROC. E-mail address: mjjeng@vghtpe.gov.tw (M.-J. Jeng). cranial abnormalities in neonates for many years. Because the anterior fontanelles of neonates remain open for a certain period of time, ultrasonography has been effectively used to detect intracranial lesions in neonates.1e11 Most neonatal patients requiring cranial ultrasonography are premature babies or sick full-term infants because they are at a high risk of having intracranial lesions.11,12 In addition, brain ultrasonography can be performed in special care units because it is easy to move the necessary equipment bedside to survey 1726-4901/$ - see front matter Copyright Ó 2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved. http://dx.doi.org/10.1016/j.jcma.2012.06.007 Author's personal copy 390 C.-L. Hsu et al. / Journal of the Chinese Medical Association 75 (2012) 389e395 patient intracranial lesions. Therefore, cranial ultrasonography is generally a safe and convenient way to rapidly evaluate intracranial conditions in neonates. In addition to high-risk neonates, some full-term neonates may have asymptomatic intracranial lesions at birth, and some of the lesions may cause long-term neurologic deficits in infants.1,8 Early screening for intracranial lesions in newborn babies has been used for early evaluation and diagnosis in some medical centers, and investigators have reported finding different intracranial lesions on the cranial ultrasonographic screening examinations.1,8 Therefore, cranial ultrasonography has been determined to be a useful tool for early diagnosis of neonatal intracranial pathologies. Cranial ultrasonographic screening has been performed for more than 10 years in many tertiary hospitals in Taiwan. A detailed analysis of these ultrasonographic findings is important to elucidate the effectiveness and clinical significance of cranial ultrasonography in healthy full-term neonates. Therefore, we designed this retrospective analysis to review and analyze the findings of cranial ultrasonography in healthy fullterm neonates during the past 5 years. 2. Methods We retrospectively reviewed all cranial ultrasonographic screening tests in healthy neonates who were born in Taipei Veterans General Hospital in Taipei, Taiwan, R.O.C., between September 2004 and August 2009. All basic characteristics of the patients and the cranial ultrasonography reports were reviewed. This retrospective study has been approved by the Institutional Review Board of Taipei Veterans General Hospital, protocol number: 2012-04013A. During that period of time, all of the examinations were performed and reported by one of 3 well-trained attending physicians (including two neonatologists and one pediatric neurologist). In addition, the same portable ultrasound system (Acuson Cypress, Model No. 08267219, Siemens Medical Solutions USA, Inc., Mountain Views, CA, USA) with the same transducer probe (Acuson 7V3C ultrasound probe, Siemens Medical Solutions USA, Inc.) was used to perform cranial ultrasonography. The settings and the scanning procedures, including at least six coronary (orbital roofs, pentagon view, third ventricle, fourth ventricle, trigones, and over the top) and seven sagittal (midline, parasagittal-right, steep parasagittal-right, sylvian fissure-right, parasagittal-left, steep parasagittal-left, sylvian fissure-left) views, were all kept consistent. The criteria for enrollment of subjects into our study were defined as follows: (a) healthy full-term neonates with gestational age between 37e42 weeks, and uneventful birth that did not require neonate admission for management or treatment except for neonatal jaundice requiring phototherapy, (b) the screening examination was requested by the family, and not at the behest of the medical staff for disease check-up, and (c) the examination was performed during the first 7 days of age. The reports of the cranial ultrasonography of all enrolled subjects were reviewed, and findings were grouped into the following three categories: (1) nonsignificant (NS) group, which included normal and normal variations, (2) minor anomaly group, which included cystic lesions, mild hemorrhage, or mild ventricular dilatation, and (3) major anomaly group, which included significant anomaly of the corpus callosum, significant ventricular dilatation, or other major anomalies of the brain. For grouping of the findings in ventricular size, the following definitions were used: (a) frontal horn prominence: solitary finding of frontal horn width 3e5 mm, (b) lateral ventricular body prominence: solitary finding of ventricular body width 3e5 mm, (c) occipital horn prominence: solitary finding of thalamo-occipital distance 15e20 mm, (d) mild ventricular dilatation: ventricular body width > 5 mm and 10 mm, and/or thalamo-occipital distance > 20 mm, and (e) significant ventricular dilatation: ventricular body width > 10 mm and thalamo-occipital distance > 20 mm.13e17 The width of the lateral ventricular body was measured at the midway position in-between frontal and occipital horn on the parasagittal view. If the reports revealed positive findings that might be grouped into minor or major anomaly groups, then another neonatologist to confirm the diagnosis and measurement would review the recorded images. The medical records of enrolled infants were also reviewed, extending through 24 months of age, to evaluate if any late onset of neurological disease occurred in the first 2 years of life. Any information regarding to neurologic image studies, or neurologic/developmental problems were recorded. 3. Results During the study period, there were a total of 6875 neonates born in Taipei Veterans General Hospital, and 3186 (1664 boys and 1522 girls, male-to-female ratio: 1.09) of them underwent cranial ultrasonographic screening testing. The birth body weight of enrolled patients was 3161  387 g (range: 2062e4486 g), and the gestational age was 39  1 weeks (range: 37e42 weeks). 3.1. NS group There were 2982 (93.60%) neonates grouped into the NS, group, including 817 cases of normal cranial structures and 2165 cases with one or more normal cranial variations. There was no significant difference between male and female infants. The most common finding within the normal cranial variations was the presence of cavum septum pellucidum, which was found in 1979 neonates (62.12% of total cases). Other variations included the presence of ventricular variations, prominence of choroid plexus or cisterna magna, cavum vergae, mild periventricular echogenicity, benign mild extracerebral fluid accumulation, and corpus callosum variations [thin (11 cases) or atypical (3 cases) appearance]. These are detailed in Table 1. Author's personal copy 391 C.-L. Hsu et al. / Journal of the Chinese Medical Association 75 (2012) 389e395 Table 1 Summary of the cranial ultrasonographic results in 3186 healthy full-term neonates. NS group Normal variation Cavum septum pellucidum Ventricular variation Frontal horn prominence Occipital horn prominence Lateral ventricular body prominence Prominence of choroid plexus Cavum vergae Prominence of cisterna magnum Corpus callosum variation Mild periventricular echogenicity Minimal extracerebral fluid collection Minor anomaly group Cyst Caudothalamic groove Choroid plexus Ventricle wall Corpus callosum Intraventricular hemorrhage Germinal matrix Choroid plexus Ventricular anomaly Mild ventricular dilatation Septations in ventricles Major anomaly group Corpus callosum agenesis Significant ventricular dilatation Total Percentageof total cases Male (%) Female (%) 2982 2165 1979 66 27 20 19 39 38 16 14 9 4 202 119 101 12 5 1 59 58 1 24 20 4 2 1 1 93.60 67.95 62.12 2.07 0.85 0.63 0.60 1.22 1.19 0.50 0.44 0.28 0.13 6.34 3.74 3.17 0.38 0.16 0.03 1.85 1.82 0.03 0.75 0.63 0.13 0.06 0.03 0.03 1554 1132 1030 36 14 11 11 15 22 10 8 8 3 105 56 48 7 0 1 34 33 1 15 13 2 2 1 1 1428 1033 949 30 13 9 8 24 16 6 6 1 1 97 63 53 5 5 0 25 25 0 9 7 2 0 0 0 (52) (52) (52) (55) (52) (55) (58) (39) (58) (63) (57) (89) (75) (52) (47) (48) (58) (0) (100) (58) (57) (100) (63) (65) (50) (100) (100) (100) (48) (48) (48) (45) (48) (45) (42) (61) (42) (37) (43) (11) (25) (48) (53) (52) (42) (100) (0) (42) (43) (0) (37) (35) (50) (0) (0) (0) More than one finding could be noted in one case. NS ¼ non-significant. 3.2. Minor anomalies There were 202 neonates (6.34%) reported with the following minor anomalies in the cranial ultrasonographic examinations, including tiny cystic lesions, mild hemorrhage, and mild ventricular anomalies. Generally, there was no significant difference between male and female infants. Cystic lesions (119 neonates, 3.74%) were the most common findings, and the caudothalamic groove was the most common site (Table 1). In addition, most cases were found to have cystic lesions at the left caudothalamic junction, or bilaterally, and less commonly found only at the right side (Table 2). Mild intraventricular hemorrhage was the second common finding (59 cases, 1.85%), and most of those cases were found Table 2 Sites of the cranial ultrasonographic findings in 3186 healthy full-term neonates. Cyst Caudothalamic junction Choroid plexus Ventricular wall Corpus callosum Ventricular variation and anomaly Frontal horn prominence Mild ventricular dilatation Occipital horn prominence Lateral ventricular body prominence Septations in ventricles Significant ventricular dilatation Hemorrhage Germinal matrix Choroid plexus Periventricular echogenicity Prominent choroid plexus Total Left (%) Right (%) Bilateral (%) No mention (%) 119 101 12 5 1 91 27 20 20 19 4 1 59 58 1 9 39 55 47 5 3 (46) (47) (42) (60) 21 15 5 1 (18) (15) (42) (20) 37 34 2 1 (31) (34) (17) (20) 6 5 0 0 (5) (5) (0) (0) 59 13 12 15 16 3 0 14 14 0 1 16 (65) (48) (60) (75) (84) (75) (0) (24) (24) (0) (11) (41) 7 3 2 1 0 1 0 19 19 0 4 6 (8) (11) (10) (5) (0) (25) (0) (32) (33) (0) (44) (15) 23 10 6 4 2 0 1 26 25 1 4 15 (25) (37) (30) (20) (11) (0) (100) (44) (43) (100) (44) (39) 2 1 0 0 1 0 0 0 0 0 0 2 (2) (4) (0) (0) (5) (0) (0) (0) (0) (0) (0.0) (5) Author's personal copy 392 C.-L. Hsu et al. / Journal of the Chinese Medical Association 75 (2012) 389e395 to have mild germinal matrix hemorrhage (58 neonates, 1.82%). These results are shown in Table 1. Bilateral germinal matrix hemorrhage was commonly found at more than just one site (Table 2). In the 24 cases of mild ventricular anomalies, most of them were reported as mild ventricular dilatation (20 cases, 0.63%). These results are shown in Table 1. Among those cases, six infants had bilateral dilatation, 12 infants had left side dilatation, and only two infants had dilatation only on the right side. In addition, there were four infants noted to have some intraventricular septums in bilateral lateral ventricles. 3.3. Major anomalies There were two neonates grouped into major anomalies, including one infant with significant ventricular dilatation and the other one noted with agenesis of corpus callosum (Table 1). The first major anomaly neonate was found to have significant ventricular dilatations in the initial cranial ultrasonography. Brain magnetic resonance imaging (MRI) revealed marked obstructive hydrocephalus with significant dilatation of bilateral lateral ventricles and the third ventricle, and the presence of a retrocerebellar arachnoid cyst with a diameter larger than 5 cm (Fig. 1). An endoscopic ventriculostomy of the third ventricle was performed when the child was 2.5 months of age. Follow-up cranial ultrasonography revealed much improvement and the presence of a small cyst (0.5 cm in diameter) at retrocerebellar region 10 months later. Tracing back to the child’s prenatal reports, there was no record of any anomaly on fetal ultrasonography. The second infant in the major anomaly group was found to have agenesis of corpus callosum, a choroid plexus cyst at the left lateral ventricle and right colpocephaly at the initial cranial ultrasonography (Fig. 2). Subsequent auditory hearing test and electroencephalography (EEG) both showed no abnormality, and there was no record regarding any neurologic problem of the child during the first 2 years. After tracing back to the child’s maternal history, dilatation of subarachnoid cisterns had been noted when the pregnancy gestation period was 32 weeks. 3.4. Cases with late onset of neurologic problems After review of the enrolled cases of NS and minor anomaly groups, there were two additional neonates later admitted due to neurological disease within 2 years after birth, the first case involved neonatal seizure and the second case a diagnosis of Moyamoya disease. In the case of neonatal seizure, the child had been found to have prominence of bilateral frontal horns in the initial cranial ultrasonography after birth, and seizure attacks began on Day 6 after the child was born. MRI and EEG did not show any abnormality. Phenobarbital was used to control the seizure. However, the patient’s mother stopped the medication on her own initiative 3 weeks later, and then there were no more seizure attacks or presence of any other new neurologic problems recorded. In the neonate case with Moyamoya disease, the child was observed to have bilateral germinal matrix hemorrhage on cranial ultrasonography after birth. However, she was unable to be located or follow-up by our hospital. Approximately 2 years later, the child was admitted to another hospital after she suffered right limbs weakness and seizure attack; Moyamoya disease was diagnosed following cranial angiography. After two neurosurgical procedures, the right limb weakness continued to progress. The child returned to our hospital when she was 2.5 years of age, and MRI and EEG revealed multiple cranial infarctions with diffuse cortical dysfunction. After her last visit to our hospital, she had ongoing challenges and had limb disabilities and mild mental retardation; she was in need of long-term rehabilitation. 4. Discussion The present study revealed that 93.6% (2892/3186) of healthy neonates undergoing cranial ultrasonographic Fig. 1. Images of T1-weighted brain magnetic resonance imaging of the neonate with obstructive hydrocephalus. Left: sagittal view of the midline brain. Right: coronary view. Arrow: retrocerebellar arachnoid cyst. Author's personal copy C.-L. Hsu et al. / Journal of the Chinese Medical Association 75 (2012) 389e395 393 Fig. 2. Cranial ultrasonographic images of the neonate with agenesis of corpus callosum. Left: sagittal view of the midline brain. There is an absence of cingulate sulcus, and the medial hemispheric sulci reach the third ventricle in a radial fashion (arrow). Middle: coronary view. A tiny subependymal cyst (arrow) is present at the left choroid plexus. Right: sagittal view of right hemisphere. Colpocephaly (arrow) is present at the right lateral ventricle. screening tests had no obvious abnormal findings. Of that number, 72.6% (2165/2982) of them had different kinds of normal variations. Some neonates (6.3%, 202/3186) had different minor abnormal findings; tiny cystic lesions were the most common (63.9%, 129/202), especially at the caudothalamic grooves. There were only two (0.06%, 2/3186) neonates who were found to have significant cranial anomalies by the screening cranial ultrasonographic examinations. There have been significant advances in the technology of medical ultrasonography in recent years. In cranial ultrasonography, it is not difficult to examine the developing cerebral surface, assess sulcal-gyral maturation, and even investigate the subtle changes in cerebral blood flow and parenchymal perfusion by using Doppler ultrasonography.4e11 Furthermore, there is no risk of any radiation exposure or invasive procedure to the frail neonatal brain while performing this examination. Therefore, the clinical role of cranial ultrasonography will become more important in future neonatal care. Using cranial ultrasonography for early identification of significant intracranial lesions in healthy full-term neonates may help clinicians to perform early and effective management to improve their patients’ neurodevelopmental outcomes.1,8 In the NS group of our present study, cavum septum pellucidum (91.4%, 1979/2165) was the most common normal variation, with a prevalence of 62.1% (1979/3186) in all examined neonates. Of course cavum septum pellucidum is typically present in all fetuses, so it is commonly seen in preterm infants. More than 85% of them may fuse by 3e6 months after birth in full-term neonates, so cavum septum pellucidum can be classified as a normal variation in full-term neonates. However, neurodevelopmental abnormalities involving midline structures had been considered, possibly having psychopathologic consequences.18e21 Although the persistent presence of cavum septum pellucidum had even been reported to be loosely associated with schizophrenia, chronic brain trauma, limbic epileptogenesis, or chromosomal anomaly,18e22 there was still no strong evidence that might establish such a relationship. Long-term follow-up of cases with the persistent presence of cavum septum pellucidum may be necessary in the future to better understand any connection with potential neurodevelopmental anomalies. Subependymal cysts and choroid plexus cysts had been reported as common findings in neonatal cranial ultrasound scans,10,23e29 and reported in 1%e5% of the neonatal population.27 The presence of an isolated subependymal cyst or a choroid plexus cyst usually resolves after a variable period of time,29 and no serious neurodevelopmental complications occur in most cases.29 However, in the meta-analysis of Alvarez and colleagues,27 they found that one in four to five infants with bilateral multiple subependymal cysts or choroid plexus cysts may have a congenital infection or genetic anomaly. Therefore, newborn infants with multiple or bilateral cranial cystic lesions should be carefully examined for the potential underlying diseases. In the present study, 3.7% (119/ 3186) of all examined neonates were found to have cystic lesions, which is similar to other reports (Table 1).27 Of those cystic lesions found, we found that 31.1% (37/119) presented as bilateral intracranial cysts (Table 2). However, we did not find any abnormal neurodevelopmental record in the following 18e24 months after discharge. A further follow-up may be necessary to identify and assess any neurodevelopmental anomalies of these neonates that may occur in the future. Intraventricular hemorrhage is common in premature infants or those of very low birth weight.30 However, it is also can be seen in full-term neonates.8,11,31e35 When the hemorrhage is restricted to grades I or II, there are often no further complications. Clinically significant intraventricular hemorrhage, such as grades III or IV, are considered to have a strong correlation with poor neurodevelopmental outcomes in neonates.30,31,35 Long-term neurologic sequelae, including epileptic disorder, perceptual difficulties, cognitive deficiencies, and mental and other neurologic handicaps, have been reported in these survivors.8,32e34 In the present study, the prevalence of asymptomatic intraventricular hemorrhage, including germinal matrix and choroid plexus hemorrhage, was less than 2% in healthy full-term neonates. Although all of these neonates exhibited no neurological deficit during the studied follow-up period, long-term observation and neurological follow-up for these infants may be necessary. Heibel and others8 had reported 3.5% (35/1000) of healthy full-term neonates had different grades of intracranial hemorrhage, and four of them developed hemipareses or infantile spasm within 1 year of birth. Wang and coauthors1 Author's personal copy 394 C.-L. Hsu et al. / Journal of the Chinese Medical Association 75 (2012) 389e395 also had reported 0.26% (6/2309) of healthy full-term neonates had major brain lesions, including intracranial hemorrhage, corpus callosum agenesis, and lacunar infarct, and four of them had significant developmental delay at the mean age of 24 months. The prevalence of intracranial major anomaly (0.06%) or intraventricular hemorrhage (1.85%) in our study were lower than described in previous reports. One possible explanation for this difference is the popularization and advancement of ultrasonographic devices and techniques. Recently, pregnant women can receive regular obstetric ultrasound follow-up before delivery, so most major lesions can be detected after 20 weeks of gestational age. Any neonates known to have any concern of significant intracranial anomalies or hemorrhage before delivery would be admitted and examined soon after birth,36,37 and, thus, not included in our survey. Therefore, the real incidence of major intracranial anomalies in neonates may be higher than suggested by the present study. Ultrasound imaging is a sensitive diagnostic tool, and can frequently detect significant ventricular dilatation and midline brain lesions. In our study cases, there was one patient with obstructive hydrocephalus that presented as marked ventricular dilatation in the initial cranial ultrasonography. After adequate surgical interventions, there was no further neurological problem reported during the following 2 years of life. In this case, definite benefits were obtained from cranial screening ultrasonographic examination. In addition, we also found that 20 infants (0.63% of all cases) had mild ventricular dilatation. Although none of those patients reported neurologic problems during the following 2 years, follow-up is still suggested. Agenesis of the corpus callosum is a rare midline brain congenital abnormality, with a reported prevalence of 0.03%e0.7% in the general population and 2.3% among developmentally disabled individuals.7,38 In our study, only one case involved a diagnosis of agenesis of the corpus callosum, so its incidence was also only 0.03% in healthy full-term infants, which is similar to other reports.7 When agenesis of the corpus callosum is diagnosed, many neurological problems, such as mental retardation or developmental delay, seizure, cerebral palsy, borderline intelligence, and other abnormalities had been reported.39 In addition, it is considered to be a component of many different syndromes.7 Although our diagnosed infant did not show any sign of neurological problem during the first 2 years of life, longterm follow-up is still necessary. Although cranial ultrasonography is a convenient technology used to detect intracranial lesions, it has some limitations, especially in minute parenchymal problems or vascular diseases such as cerebral infarction, minor vascular anomalies or small hemangiomas.40 We did find two cases (0.06% of all neonates) with late onset of neurologic problems even with normal or minor anomaly in the initial cranial ultrasonographic examination, so the cranial ultrasonography could not expose all neurologic pathology in neonates. Clinical alertness to any sign of neurologic deficit is important for all infants even if they have been examined with cranial ultrasonography in the early neonatal period. The retrospective study design has a benefit that we could conclude more than 3000 infants who had previously received the cranial ultrasonography at birth. However, the retrospective design is also the major limitation of the present study, so there was no well designed neurologic/developmental follow-up. Furthermore, not all enrolled infants kept visiting our hospital during the following 24 months. The incidence of late onset neurologic problems might be higher than we have found in the medical charts. A future study with prospective design for a longer period of time should be done in the future for elucidating the residual questions on the diagnostic value of neonatal cranial ultrasonographic screening test. In conclusion, the incidence of minor and major anomalies detected by cranial ultrasonographic screening examinations in healthy full-term neonates is 6.3% and 0.06%, respectively. Thus, cranial ultrasonographic screening may play a role in the early diagnosis of intracranial anomalies of healthy full-term neonates. However, this examination cannot exclude all neurologic diseases of neonates, so it is important for practitioners to remain clinically alert for all infants. References 1. Wang LW, Huang CC, Yeh TF. Major brain lesions detected on sonographic screening of apparently normal term neonates. Neuroradiology 2004;46:368e73. 2. Steggerda SJ, Leijser LM, Walther FJ, van Wezel-Meijler G. Neonatal cranial ultrasonography: how to optimize its performance. Early Hum Dev 2009;85:93e9. 3. Barr LL. Neonatal cranial ultrasound. Radiol Clin North Am 1999;37:1127e46. 4. Ng VW, MacSweeney JE. Ultrasound of the neonatal brain. Br J Hosp Med 1997;57:19e22. 5. Glaubic-Latka M, Latka D, Bury W. The perspectives of ultrasound use in neurological diagnosis. Neurol Neurochir Pol 1999;33:883e95. 6. Carson SC, Hertzberg BS, Bowie JD, Burger PC. Value of sonography in the diagnosis of intracranial hemorrhage and periventricular leukomalacia: a postmortem study of 35 cases. Am J Roentgenol 1990;155:595e601. 7. Penny SM. Agenesis of the corpus callosum: neonatal sonographic detection. Radiol Technol 2006;78:14e8. 8. Heibel M, Heber R, Bechinger D, Kornhuber HH. Early diagnosis of perinatal cerebral lesions in apparently normal full-term newborns by ultrasound of the brain. Neuroradiology 1993;35:85e91. 9. Hayden CK, Shattuck KE, Richardson CJ, Ahrendt DK, House R, Swischuk LE. Subependymal germinal matrix hemorrhage in full-term neonates. Pediatrics 1985;75:714e8. 10. Shen EY, Huang FY. Subependymal cysts in normal neonates. Arch Dis Child 1985;60:1072e4. 11. Scher MS, Wright FS, Lockman LA, Thompson TR. Intraventricular hemorrhage in the full-term neonate. Arch Neurol 1982;39:769e72. 12. Oelberg DG, Temple DM, Haskins S, Bigelow RH, Adcock EW. Intracranial hemorrhage in term or near term newborns with persistent pulmonary hypertensions. Clin Pediatr 1988;27:14e7. 13. Perry RN, Bowman ED, Murton LJ, Roy RN, de Crespigny LC. Ventricular size in newborn infants. J Ultrasound Med 1985;4:475e7. 14. Allan WC, Holt PJ, Sawyer LR, Tito AM, Meade SK. Ventricular dilation after neonatal periventricular-intraventricular hemorrhage. Natural history and therapeutic implications. Am J Dis Child 1982;136:589e93. 15. Brouwer MJ, de Vries LS, Groenendaal F, Koopman C, Pistorius LR, Mulder EJ, et al. New reference values for the neonatal cerebral ventricles. Radiology 2012;262:224e33. Author's personal copy C.-L. Hsu et al. / Journal of the Chinese Medical Association 75 (2012) 389e395 16. Behnke M, Eyler FD, Garvan CW, Tenholder MJ, Wobie K, Woods NS, et al. Cranial ultrasound abnormalities identified at birth: their relationship to perinatal risk and neurobehavioral outcome. Pediatrics 1999;103:e41. 17. Sondhi V, Gupta G, Gupta PK, Patnaik SK, Tshering K. Establishment of nomograms and reference ranges for intra-cranial ventricular dimensions and ventriculo-hemispheric ratio in newborns by ultrasonography. Acta Paediatr 2008;97:738e44. 18. Galarza M, Merlo A, Ingratta A, Albanese E, Albanese A. Cavum septum pellucidum and its increased prevalence in schizophrenia: a neuroembryological classification. J Neuropsychiatry Clin Neurosci 2004;16:41e6. 19. Zhang L, Ravdin L, Relkin N, Zimmerman R, Jordan B, Lathan W, et al. Increased diffusion in the brain of professional boxers: a preclinical sign of traumatic brain injury? AJNR Am J Neuroradiol 2003;24:52e7. 20. Iannetti P, Papetti L, Nicita F, Castronovo A, Ursitti F, Parisi P, et al. Developmental anomalies of the medial septal area: possible implication for limbic epileptogenesis. Childs Nerv Syst 2011;27:765e70. 21. Kasai K, McCarley RW, Salisbury DF, Onitsuka T, Demeo S, YurgelunTodd D, et al. Cavum septi pellucidi in first-episode schizophrenia and first-episode affective psychosis: an MRI study. Schizophr Res 2004;71:65e76. 22. Beaton EA, Qin Y, Nguyen V, Johnson J, Pinter JD, Simon TJ. Increased incidence and size of cavum septum pellucidum in children with chromosome 22q11.2 deletion syndrome. Psychiatry Res 2010;181:108e13. 23. van Baalen A, Rohr A. From fossil to fetus: nonhemorrhagic germinal matrix echodensity caused by mineralizing vasculitis-hypothesis of fossilizing germinolysis and gliosis. J Child Neurol 2009;24:36e44. 24. van Baalen A, Versmold H. Anterior choroid plexus cysts: distinction from germinolysis by high-resolution sonography. Pediatr Int 2008;50:57e61. 25. van Baalen A, Versmold H. Non-haemorrhagic subependymal pseudocysts: ultrasonographic, histological and pathogenetic variability. Ultraschall Med 2007;28:296e300. 26. Herini E, Tsuneishi S, Takada S, Sunarini, Nakamura H. Clinical features of infants with subependymal germinolysis and choroid plexus cysts. Pediatr Int 2003;45:692e6. 27. Fernandez Alvarez JR, Amess PN, Gandhi RS, Rabe H. Diagnostic value of subependymal pseudocysts and choroid plexus cysts on neonatal 28. 29. 30. 31. 32. 33. 34. 35. 36. 37. 38. 39. 40. 395 cerebral ultrasound: a meta-analysis. Arch Dis Child Fetal Neonatal Ed 2009;94:F443e6. Smets K, Schwagten B. Postnatal cystic germinolysis and neonatal chronic lung disease: evaluation of risk factors and neurodevelopmental outcome. Acta Paediatr 2000;89:1111e4. Larcos G, Gruenewald SM, Lui K. Neonatal subependymal cysts detected by sonography: prevalence, sonographic findings, and clinical significance. AJR Am J Roentgenol 1994;162:953e6. Sarkar S, Bhagat I, Dechert R, Schumacher RE, Donn SM. Severe intraventricular hemorrhage in preterm infants: comparison of risk factors and short-term neonatal morbidities between grade 3 and grade 4 intraventricular hemorrhage. Am J Perinatol 2009;26:419e24. Jocelyn LJ, Casiro OG. Neurodevelopmental outcome of the term infants with intraventricular hemorrhage. Am J Dis Child 1992;146:194e7. Hanigan WC, Powell FC, Palagallo G, Miller TC. Lobar hemorrhage in full-term neonates. Child’s Nerv Syst 1995;11:276e80. Bergman I, Bauer RE, Barmada MA, Latchaw RE, Taylor HG, David R, et al. Intracerebral hemorrhage in the full-term neonatal infant. Pediatrics 1985;75:488e96. Fenichel GM, Webster DL, Wong WKT. Intracranial hemorrhages in the term newborn. Arch Neurol 1984;41:30e4. Mao C, Guo J, Chituwo BM. Intraventricular haemorrhage and its prognosis, prevention and treatment in term infants. J Trop Pediatr 1999;45:237e40. Hwang KS, Ding DC, Chang YK, Chen WH, Chu TY. Otocephaly. J Chin Med Assoc 2007;70:298e301. Karadeniz L, Coban A, Sencer S, Has R, Ince Z, Can G. Vein of Galen aneurysmal malformation: prenatal diagnosis and early endovascular management. J Chin Med Assoc 2011;74:134e7. Jeret JS, Serur D, Wisniewski K, Fisch C. Frequency of agenesis of the corpus callosumin the developmentally disable population as determined by computerized tomography. Pediatr Neurosci 1986;12:101e3. Serur D, Jenet JS, Wisniewski K. Agenesis of the corpus callosum: clinical, neuroradiological and cytogenic studies. Neuropediatrics 1988;19:87e91. Estan J, Hope P. Unilateral neonatal cerebral infarction in full-term infants. Arch Dis Child 1997;76:F88e93.